tiprankstipranks
Trending News
More News >
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market

Nurix Therapeutics (NRIX) Revenue

Compare
426 Followers

Nurix Therapeutics Revenue

Nurix Therapeutics had a revenue of 18.45M in the quarter ending Mar 31, 2025, with 38.91%. This bring the company's revenue in the last twelve months to 56.42M, Decreased 3.42%. In the fiscal year ending Dec 31, 2024, Nurix Therapeutics had annual revenue of 54.55M with -29.15% growth.
Revenue (ttm)
56.42M
Revenue Growth
-30.25%
P/S Ratio
16.16
Revenue/Employee
$190,731
Employees
286
Market Cap
$881.28M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202454.55M-22.44M-29.15%
Dec 31, 202376.99M38.36M+99.31%
Dec 31, 202238.63M8.88M+29.84%
Dec 31, 202129.75M11.93M+66.95%
Dec 31, 202017.82M-13.29M-42.73%
Dec 31, 201931.11M-6.33M-16.91%
Dec 31, 201837.45M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis